Skip to main content
. 2008 Dec 17;100(24):1755–1762. doi: 10.1093/jnci/djn383

Table 3.

Value of life lost due to cancer deaths in the year 2000 by sex and tumor site in billions of dollars*

Tumor site Men Women
<65 years (billion $) ≥65 years (billion $) <65 years (billion $) ≥65 years (billion $)
Lung 66.1 82.3 50.1 72.3
Breast 51.3 33.9
Prostate 5.5 29.3
Colorectal 20.7 24.1 17.2 28.8
Pancreas 12.1 12.3 8.9 16.6
Ovary 13.9 13.8
Leukemia 10.7 9.8 8.4 9.1
Lymphoma (non-Hodgkin) 10.0 9.6 6.8 11.1
Esophagus 9.4 7.7 1.9 3.1
Urinary bladder 3.4 7.7 1.4 4.2
Liver 9.6 6.4 3.6 5.1
Kidney 7.2 5.8 3.4 4.6
Gastric 6.1 5.9 3.8 5.0
Head and neck 7.8 5.3 2.4 2.9
Brain and ONS 11.5 4.2 8.6 4.6
Cervix 8.2 2.2
Corpus uteri 5.2 6.9
Melanoma of the skin 6.0 3.2 3.8 2.2
Lymphoma (Hodgkin) 1.4 0.4 1.1 0.4
Testis 1.1 0.1
All cancers 222.4 245.8 227.9 264.5
*

Tumor sites are listed from highest to lowest sex-specific age-adjusted mortality rate. — = not available or not applicable to this population; ONS = other neurologic sites. Value of life lost was estimated using a previously published value of 1 year of life ($150 000) applied to the person-years of life lost estimate for each tumor site. All value of life lost estimates were discounted by 3% annually and reported in real dollars.